大洋洲 · 股市与财经 · Australian Financial Review
CSL signs drug deal with Swiss biotech giant to fight rare disease
The Australian pharma giant believes the drug will be an important therapeutic option to improve kidney function.
在 Australian Financial Review 阅读全文 登录后可收藏MediaNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.afr.com)
